• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    More On BLRX.TA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    BioLineRx, Ltd. (BLRX.TA)

    -Tel Aviv
    398.40 Down 2.30(0.57%) 10:24AM EST
    Prev Close:400.70
    Open:400.70
    Bid:389.30 x 39000
    Ask:390.10 x 2600
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:394.00 - 403.00
    52wk Range:3.68 - 403.00
    Volume:26,903
    Avg Vol (3m):102,167
    Market Cap:21.84B
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in ILS.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback